Looking Into Pacira BioSciences’s Return On Capital Employed
Pacira BioSciences (NASDAQ:PCRX) brought in sales totaling $160.34 million during Q1 according to data provided by Benzinga Pro.…
Why Pacira BioSciences Shares Are Trading Lower Today
Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the
Recap: Pacira BioSciences Q1 Earnings
Pacira BioSciences (NASDAQ:PCRX) reported its Q1 earnings results on Wednesday, May 3, 2023 at 08:00 AM. Here’s what…
Pacira BioSciences Expects FY23 EXPAREL Revenue $570M – $580M, ZILRETTA Revenue $1125M – $125M
Reconciliation of GAAP to Non-GAAP 2023 Financial Guidance
(dollars in millions)
GAAP to Non-GAAP Guidance
GAAP
Full-year Impact of GAAP to Non-GAAP Adjustments
What 6 Analyst Ratings Have To Say About Pacira BioSciences
Pacira BioSciences (NASDAQ:PCRX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
RBC Capital Maintains Outperform on Pacira BioSciences, Lowers Price Target to $76
RBC Capital analyst Gregory Renza maintains Pacira BioSciences (NASDAQ:PCRX) with a Outperform and lowers the price target from $80 to $76.
Analyst Expectations for Pacira BioSciences’s Future
Analysts have provided the following ratings for Pacira BioSciences (NASDAQ:PCRX) within the last quarter: Bullish Somewhat Bullish Indifferent…
Needham Maintains Buy on Pacira BioSciences, Lowers Price Target to $60
Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and lowers the price target from $63 to $60.
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session.
